To investigate differences in pathological protein spreading between AD subtypes, Vogel and colleagues [55] used tau-PET imaging data from 1,612 subjects and the Subtype and Stage Inference (SuStaIn) model to establish the spectrum of AD. The gene discussed is MAPT; the disease is Alzheimer disease.